Summary
Patients who had brain metastases following bevacizumab and chemotherapy (CT) for non-squamous, non—small cell lung cancer (non-Sq NSCLC) were safely treated with whole-brain radiotherapy, with a good response and symptom improvement.
- Radiology
- Radiation Therapy
- Respiratory Cancers Clinical Trials
- Head & Neck Cancers
- Radiology
- Radiation Therapy
- Respiratory Cancers
- Oncology
- Oncology Clinical Trials
- Head & Neck Cancers
- © 2014 MD Conference Express®
Tools
Brain Metastases Safely Treated with WBRT after Bevacizumab and Chemotherapy in NSCLC
Permalink:
Table of contents
Cited By...
- No citing articles found.